Bio-Techne Corporation, in collaboration with Wilson Wolf Manufacturing and CellReady, has announced that the Gates Institute's Translational Sciences Laboratory has been awarded a $300,000 G-Rex® Grant. This grant will be used to develop a modular G-Rex centric CAR T-cell manufacturing platform at the University of Colorado Anschutz Medical Campus. The funding aims to optimize cell and gene therapy manufacturing processes, aligning with the Gates Institute's goals to enhance efficiency and adaptability. This initiative highlights the collective efforts of multiple organizations, including Bio-Techne, to advance cell and gene therapy technologies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.